PharmaBoardroom

Life Science VC Funding in Japan: Signs of Growth & Untapped…

Toshio Fujimoto, MD, MBA, the General Manager of Shonan Health Innovation Park examines why Japan – despite being well established as one of the…

Charles Stacey – President & CEO, Cerecin

Cerecin’s Charles Stacey outlines the company’s progress in expanding its lead asset into migraine and infantile spasms, how its funding strategy…

China: EpimAb Looks to 2022 IPO & Global Leadership in…

Hot on the heels of a USD 120 million fundraising round, Shanghai-based EpimAb Biotherapeutics is now looking towards a 2022 IPO with the aim of…

Switzerland Biotech Listing Snapshot 2021

The SXI Bio & MedTech Index outperformed the Swiss Performance Index (SPI) by 38 percent and NASDAQ Biotech by 46 per cent between 2015 and 2020.…

Sizhen Wang – CEO & Co-Founder, Genetron Health

Genetron Health is a publicly-traded China-based precision oncology company, covering the “full-cycle” of cancer care, from early screening,…

Top 10 Fastest Growing Private UK Pharma Companies 2021

The top 10 fastest-growing private pharma companies in the UK for 2021, compiled by corporate finance advisory firm Alantra. Featured companies…

China Pharma News: Antitrust Threat to Pharma; June BioNTech…

The latest China pharma news, including the upcoming first domestic approval for a foreign COVID-19 vaccine in June; the potential of Western China as…

UK Pharma News: Fastest Growing Private Pharmacos; GSK Shake-Up;…

The latest UK pharma news, including how new investment in GSK stands to reshape the country’s iconic pharma giant; CDMO Sterling’s latest…

Michael Altorfer – CEO, Swiss Biotech Association

Michael Altorfer, CEO of the Swiss Biotech Association, a membership organisation representing the interests of the Swiss biotech industry, discusses…